| 000 | 01502 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511233214.0 | ||
| 264 | 0 | _c19900315 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.40.2.229 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKermode, A G | |
| 245 | 0 | 0 |
_aHeterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. _h[electronic resource] |
| 260 |
_bNeurology _cFeb 1990 |
||
| 300 |
_a229-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlood-Brain Barrier |
| 650 | 0 | 4 |
_aContrast Media _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGadolinium _xpharmacokinetics |
| 650 | 0 | 4 | _aGadolinium DTPA |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImage Enhancement |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xmetabolism |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacokinetics |
| 650 | 0 | 4 |
_aPentetic Acid _xpharmacokinetics |
| 700 | 1 | _aTofts, P S | |
| 700 | 1 | _aThompson, A J | |
| 700 | 1 | _aMacManus, D G | |
| 700 | 1 | _aRudge, P | |
| 700 | 1 | _aKendall, B E | |
| 700 | 1 | _aKingsley, D P | |
| 700 | 1 | _aMoseley, I F | |
| 700 | 1 | _adu Boulay, E P | |
| 700 | 1 | _aMcDonald, W I | |
| 773 | 0 |
_tNeurology _gvol. 40 _gno. 2 _gp. 229-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.40.2.229 _zAvailable from publisher's website |
| 999 |
_c2306318 _d2306318 |
||